Key result
Frailty at admission was an independent predictor of death or nonfatal myocardial reinfarction in elderly patients with type 1 myocardial infarction (aHR 2.54; 95% CI 1.12-5.79).
Why the study?
Does frailty predict death or nonfatal myocardial reinfarction in elderly patients (≥75 years) with type 1 myocardial infarction?
Cohort (n=234)
Yes
Does frailty predict death or nonfatal myocardial reinfarction in elderly patients (≥75 years) with type 1 myocardial infarction?
Hazard Ratio: 2.54 (95% CI 1.12–5.79)
Frailty is a common and independent predictor of severe adverse events in elderly patients with acute coronary syndrome and should be considered in risk stratification.
Supports integrating frailty assessments into routine risk stratification for older adults with acute MI; leaves open.
BACKGROUND: Acute coronary syndrome (ACS) patients are increasingly older. Conventional prognostic scales include chronological age but do not consider vulnerability. In elderly patients, a frail phenotype represents a better reflection of biological age. HYPOTHESIS: This study aims to determine the prevalence of frailty and its influence on patients age ≥75 years with ACS. METHODS: Patients age ≥75 years admitted due to type 1 myocardial infarction were included in 2 tertiary hospitals, and clinical data were collected prospectively. Frailty was defined at admission using the previously validated Survey of Health Ageing and Retirement in Europe Frailty Index (SHARE-FI) tool. The primary endpoint was the combination of death or nonfatal myocardial reinfarction during a follow-up of 6 months. Major bleeding (hemoglobin decrease ≥3 g/dL or transfusion needed) and readmission rates were also explored. RESULTS: A total of 234 consecutive patients were included. Frail patients (40.2%) had a higher-risk profile, based on higher age and comorbidities. On multivariate analysis, frailty was an independent predictor of the combination of death or nonfatal myocardial reinfarction (adjusted hazard ratio [aHR]: 2.54, 95% confidence interval [CI]: 1.12-5.79), an independent predictor of the combination of death, nonfatal myocardial reinfarction, or major bleeding (aHR: 2.14, 95% CI: 1.13-4.04), and an independent predictor of readmission (aHR: 1.80, 95% CI: 1.00-3.22). CONCLUSIONS: Frailty phenotype at admission is common among elderly patients with ACS and is an independent predictor for severe adverse events. It should be considered in future risk-stratification models.
No takes yet. Share an insight, caveat, or question.
Salinas et al. (2017) conducted a cohort in Type 1 myocardial infarction (n=234). Frailty vs. Non-frail was evaluated on Combination of death or nonfatal myocardial reinfarction (aHR 2.54, 95% CI 1.12-5.79). Frailty at admission was an independent predictor of death or nonfatal myocardial reinfarction in elderly patients with type 1 myocardial infarction (aHR 2.54; 95% CI 1.12-5.79).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: